世界の核酸ベース診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nucleic Acid–Based Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4201
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、核酸ベース診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（核酸分子ハイブリダイゼーション、ポリメラーゼ連鎖反応、サーモスタット増幅、遺伝子シーケンシング、バイオチップ技術）、用途別市場規模（病院、臨床検査室、研究機関、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・核酸ベース診断の市場動向
・企業の競争状況、市場シェア
・核酸ベース診断の種類別市場規模（核酸分子ハイブリダイゼーション、ポリメラーゼ連鎖反応、サーモスタット増幅、遺伝子シーケンシング、バイオチップ技術）
・核酸ベース診断の用途別市場規模（病院、臨床検査室、研究機関、診療所、その他）
・核酸ベース診断の北米市場規模2016-2027（アメリカ、カナダ）
・核酸ベース診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・核酸ベース診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・核酸ベース診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・核酸ベース診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Agilent Technologies、Danaher Corporation、Abbott Laboratories、BD、Bio-Rad Laboratories、Roche、Illumina, Inc、Thermo Fisher Scientific Inc.、Merck KGaA、Qiagen）
・結論

Nucleic acid diagnosis is a method of diagnosis of human body state and disease by using the theory and technology of molecular biology to directly investigate the existence state or defect of nucleic acid, analyze the function of nucleic acid from the nucleic acid structure, replication, transcription or translation level.Its target molecule is DNA or RNA, which reflects the structure and function of nucleic acids.The genes tested are endogenous (that is, the body’s own genes) and exogenous (such as viruses, bacteria, etc.), the former is used to diagnose whether the gene has disease, the latter is used to diagnose whether there is pathogen infection.

Market Analysis and Insights: Global Nucleic Acid–Based Diagnostic Market
The global Nucleic Acid–Based Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nucleic Acid–Based Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nucleic Acid–Based Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nucleic Acid–Based Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nucleic Acid–Based Diagnostic market.

Global Nucleic Acid–Based Diagnostic Scope and Market Size
Nucleic Acid–Based Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nucleic Acid–Based Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nucleic Acid Molecular Hybridization
Polymerase Chain Reaction
Thermostatic Amplification
Gene Sequencing
Biochip Technology

Segment by Application
Hospital
Clinical Laboratory
Research Institutions
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Agilent Technologies
Danaher Corporation
Abbott Laboratories
BD
Bio-Rad Laboratories
Roche
Illumina, Inc
Thermo Fisher Scientific Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid–Based Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nucleic Acid Molecular Hybridization
1.2.3 Polymerase Chain Reaction
1.2.4 Thermostatic Amplification
1.2.5 Gene Sequencing
1.2.6 Biochip Technology
1.3 Market by Application
1.3.1 Global Nucleic Acid–Based Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinical Laboratory
1.3.4 Research Institutions
1.3.5 Clinic
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nucleic Acid–Based Diagnostic Market Perspective (2016-2027)
2.2 Nucleic Acid–Based Diagnostic Growth Trends by Regions
2.2.1 Nucleic Acid–Based Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nucleic Acid–Based Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Nucleic Acid–Based Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Nucleic Acid–Based Diagnostic Industry Dynamic
2.3.1 Nucleic Acid–Based Diagnostic Market Trends
2.3.2 Nucleic Acid–Based Diagnostic Market Drivers
2.3.3 Nucleic Acid–Based Diagnostic Market Challenges
2.3.4 Nucleic Acid–Based Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid–Based Diagnostic Players by Revenue
3.1.1 Global Top Nucleic Acid–Based Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Nucleic Acid–Based Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid–Based Diagnostic Revenue
3.4 Global Nucleic Acid–Based Diagnostic Market Concentration Ratio
3.4.1 Global Nucleic Acid–Based Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid–Based Diagnostic Revenue in 2020
3.5 Nucleic Acid–Based Diagnostic Key Players Head office and Area Served
3.6 Key Players Nucleic Acid–Based Diagnostic Product Solution and Service
3.7 Date of Enter into Nucleic Acid–Based Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid–Based Diagnostic Breakdown Data by Type
4.1 Global Nucleic Acid–Based Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Type (2022-2027)

5 Nucleic Acid–Based Diagnostic Breakdown Data by Application
5.1 Global Nucleic Acid–Based Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nucleic Acid–Based Diagnostic Market Size (2016-2027)
6.2 North America Nucleic Acid–Based Diagnostic Market Size by Type
6.2.1 North America Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Nucleic Acid–Based Diagnostic Market Size by Type (2016-2027)
6.3 North America Nucleic Acid–Based Diagnostic Market Size by Application
6.3.1 North America Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Nucleic Acid–Based Diagnostic Market Size by Application (2016-2027)
6.4 North America Nucleic Acid–Based Diagnostic Market Size by Country
6.4.1 North America Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Nucleic Acid–Based Diagnostic Market Size (2016-2027)
7.2 Europe Nucleic Acid–Based Diagnostic Market Size by Type
7.2.1 Europe Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Nucleic Acid–Based Diagnostic Market Size by Type (2016-2027)
7.3 Europe Nucleic Acid–Based Diagnostic Market Size by Application
7.3.1 Europe Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Nucleic Acid–Based Diagnostic Market Size by Application (2016-2027)
7.4 Europe Nucleic Acid–Based Diagnostic Market Size by Country
7.4.1 Europe Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Type
8.2.1 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Application
8.3.1 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region
8.4.1 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nucleic Acid–Based Diagnostic Market Size (2016-2027)
9.2 Latin America Nucleic Acid–Based Diagnostic Market Size by Type
9.2.1 Latin America Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Nucleic Acid–Based Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Nucleic Acid–Based Diagnostic Market Size by Application
9.3.1 Latin America Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Nucleic Acid–Based Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Nucleic Acid–Based Diagnostic Market Size by Country
9.4.1 Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type
10.2.1 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application
10.3.1 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country
10.4.1 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Nucleic Acid–Based Diagnostic Introduction
11.1.4 Agilent Technologies Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.1.5 Agilent Technologies Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Details
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Nucleic Acid–Based Diagnostic Introduction
11.2.4 Danaher Corporation Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.2.5 Danaher Corporation Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Nucleic Acid–Based Diagnostic Introduction
11.3.4 Abbott Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Nucleic Acid–Based Diagnostic Introduction
11.4.4 BD Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.4.5 BD Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Introduction
11.5.4 Bio-Rad Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Nucleic Acid–Based Diagnostic Introduction
11.6.4 Roche Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Details
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Nucleic Acid–Based Diagnostic Introduction
11.7.4 Illumina, Inc Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.7.5 Illumina, Inc Recent Development
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Details
11.8.2 Thermo Fisher Scientific Inc. Business Overview
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Introduction
11.8.4 Thermo Fisher Scientific Inc. Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.8.5 Thermo Fisher Scientific Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Nucleic Acid–Based Diagnostic Introduction
11.9.4 Merck KGaA Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid–Based Diagnostic Introduction
11.10.4 Qiagen Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021)
11.10.5 Qiagen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nucleic Acid–Based Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nucleic Acid Molecular Hybridization
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Key Players of Thermostatic Amplification
Table 5. Key Players of Gene Sequencing
Table 6. Key Players of Biochip Technology
Table 7. Global Nucleic Acid–Based Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nucleic Acid–Based Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nucleic Acid–Based Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nucleic Acid–Based Diagnostic Market Share by Regions (2016-2021)
Table 11. Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nucleic Acid–Based Diagnostic Market Share by Regions (2022-2027)
Table 13. Nucleic Acid–Based Diagnostic Market Trends
Table 14. Nucleic Acid–Based Diagnostic Market Drivers
Table 15. Nucleic Acid–Based Diagnostic Market Challenges
Table 16. Nucleic Acid–Based Diagnostic Market Restraints
Table 17. Global Nucleic Acid–Based Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nucleic Acid–Based Diagnostic Market Share by Players (2016-2021)
Table 19. Global Top Nucleic Acid–Based Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid–Based Diagnostic as of 2020)
Table 20. Ranking of Global Top Nucleic Acid–Based Diagnostic Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nucleic Acid–Based Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nucleic Acid–Based Diagnostic Product Solution and Service
Table 24. Date of Enter into Nucleic Acid–Based Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type (2016-2021)
Table 28. Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nucleic Acid–Based Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Application (2016-2021)
Table 32. Global Nucleic Acid–Based Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 64. Agilent Technologies Company Details
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies Nucleic Acid–Based Diagnostic Product
Table 67. Agilent Technologies Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 68. Agilent Technologies Recent Development
Table 69. Danaher Corporation Company Details
Table 70. Danaher Corporation Business Overview
Table 71. Danaher Corporation Nucleic Acid–Based Diagnostic Product
Table 72. Danaher Corporation Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 73. Danaher Corporation Recent Development
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Nucleic Acid–Based Diagnostic Product
Table 77. Abbott Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. BD Company Details
Table 80. BD Business Overview
Table 81. BD Nucleic Acid–Based Diagnostic Product
Table 82. BD Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 83. BD Recent Development
Table 84. Bio-Rad Laboratories Company Details
Table 85. Bio-Rad Laboratories Business Overview
Table 86. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product
Table 87. Bio-Rad Laboratories Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 88. Bio-Rad Laboratories Recent Development
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Nucleic Acid–Based Diagnostic Product
Table 92. Roche Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 93. Roche Recent Development
Table 94. Illumina, Inc Company Details
Table 95. Illumina, Inc Business Overview
Table 96. Illumina, Inc Nucleic Acid–Based Diagnostic Product
Table 97. Illumina, Inc Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 98. Illumina, Inc Recent Development
Table 99. Thermo Fisher Scientific Inc. Company Details
Table 100. Thermo Fisher Scientific Inc. Business Overview
Table 101. Thermo Fisher Scientific Inc. Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 102. Thermo Fisher Scientific Inc. Recent Development
Table 103. Merck KGaA Company Details
Table 104. Merck KGaA Business Overview
Table 105. Merck KGaA Nucleic Acid–Based Diagnostic Product
Table 106. Merck KGaA Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 107. Merck KGaA Recent Development
Table 108. Qiagen Company Details
Table 109. Qiagen Business Overview
Table 110. Qiagen Nucleic Acid–Based Diagnostic Product
Table 111. Qiagen Revenue in Nucleic Acid–Based Diagnostic Business (2016-2021) & (US$ Million)
Table 112. Qiagen Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid–Based Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Nucleic Acid Molecular Hybridization Features
Figure 3. Polymerase Chain Reaction Features
Figure 4. Thermostatic Amplification Features
Figure 5. Gene Sequencing Features
Figure 6. Biochip Technology Features
Figure 7. Global Nucleic Acid–Based Diagnostic Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinical Laboratory Case Studies
Figure 10. Research Institutions Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Nucleic Acid–Based Diagnostic Report Years Considered
Figure 14. Global Nucleic Acid–Based Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Nucleic Acid–Based Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Nucleic Acid–Based Diagnostic Market Share by Regions: 2020 VS 2027
Figure 17. Global Nucleic Acid–Based Diagnostic Market Share by Regions (2022-2027)
Figure 18. Global Nucleic Acid–Based Diagnostic Market Share by Players in 2020
Figure 19. Global Top Nucleic Acid–Based Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nucleic Acid–Based Diagnostic as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Nucleic Acid–Based Diagnostic Revenue in 2020
Figure 21. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type (2016-2021)
Figure 22. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type (2022-2027)
Figure 23. North America Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Nucleic Acid–Based Diagnostic Market Share by Type (2016-2027)
Figure 25. North America Nucleic Acid–Based Diagnostic Market Share by Application (2016-2027)
Figure 26. North America Nucleic Acid–Based Diagnostic Market Share by Country (2016-2027)
Figure 27. United States Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Nucleic Acid–Based Diagnostic Market Share by Type (2016-2027)
Figure 31. Europe Nucleic Acid–Based Diagnostic Market Share by Application (2016-2027)
Figure 32. Europe Nucleic Acid–Based Diagnostic Market Share by Country (2016-2027)
Figure 33. Germany Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Nucleic Acid–Based Diagnostic Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Nucleic Acid–Based Diagnostic Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Nucleic Acid–Based Diagnostic Market Share by Region (2016-2027)
Figure 43. China Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Nucleic Acid–Based Diagnostic Market Share by Type (2016-2027)
Figure 51. Latin America Nucleic Acid–Based Diagnostic Market Share by Application (2016-2027)
Figure 52. Latin America Nucleic Acid–Based Diagnostic Market Share by Country (2016-2027)
Figure 53. Mexico Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Nucleic Acid–Based Diagnostic Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Nucleic Acid–Based Diagnostic Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Nucleic Acid–Based Diagnostic Market Share by Country (2016-2027)
Figure 59. Turkey Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Nucleic Acid–Based Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Agilent Technologies Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 63. Danaher Corporation Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 65. BD Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 66. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 68. Illumina, Inc Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 69. Thermo Fisher Scientific Inc. Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 70. Merck KGaA Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 71. Qiagen Revenue Growth Rate in Nucleic Acid–Based Diagnostic Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の核酸ベース治療薬市場規模・現状・予測（2021年-2027年）

Global Nucleic Acid-based Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4202 2021年4月 92Pages
QYResearch社発行の本調査資料では、核酸ベース治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アンチセンス＆抗遺伝子、抑制短配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、アプタマー）、用途別市場規模（病院、学術研究機関）、...

世界の核酸ラベリング市場規模・現状・予測（2021年-2027年）

Global Nucleic Acid Labeling Market Size, Status and Forecast 2021-2027
QYR2104Z4199 2021年4月 95Pages
QYResearch社発行の本調査資料では、核酸ラベリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬＆キット、サービス）、用途別市場規模（診断センター、研究センター、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の核酸増幅検査市場規模・現状・予測（2021年-2027年）

Global Nucleic Acid Amplification Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4198 2021年4月 97Pages
QYResearch社発行の本調査資料では、核酸増幅検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ターゲット増幅システム、プローブ増幅システム、信号増幅）、用途別市場規模（感染症、がん、個別化医療、遺伝性＆ミトコンドリア病）、主要地域別市...

世界の核酸検査市場規模・現状・予測（2021年-2027年）

Global Nucleic Acid Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4200 2021年4月 97Pages
QYResearch社発行の本調査資料では、核酸検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（転写媒介増幅（TMA）、ポリメラーゼ連鎖反応（PCR）、リガーゼ連鎖反応（LCR）、全ゲノムシーケンス）、用途別市場規模（病院、病理学研究所、研...

世界の等温核酸増幅技術（INAAT）市場規模・現状・予測（2021年-2027年）

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size, Status and Forecast 2021-2027
QYR2104Z3289 2021年4月 159Pages
QYResearch社発行の本調査資料では、等温核酸増幅技術（INAAT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ループ媒介等温増幅、核酸配列増幅、ローリングサークル増幅、シングルプライマー等温増幅、ヘリカーゼ依存性等温DNA増幅、リコ...

世界の腫瘍学ベース分子診断市場規模・現状・予測（2021年-2027年）

Global Oncology Based Molecular Diagnostic Market Size, Status and Forecast 2021-2027
QYR2104Z4254 2021年4月 99Pages
QYResearch社発行の本調査資料では、腫瘍学ベース分子診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬）、用途別市場規模（乳がん、前立腺がん、結腸直腸がん、子宮頸がん、肝臓がん、肺がん、血液がん、腎臓がん）、主要地域別市場規...

世界の分子式インフルエンザ診断市場規模・現状・予測（2021年-2027年）

Global Molecular Influenza Diagnostic Market Size, Status and Forecast 2021-2027
QYR2104Z3895 2021年4月 93Pages
QYResearch社発行の本調査資料では、分子式インフルエンザ診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（逆転写ポリメラーゼ連鎖反応（RT-PCR）、核酸配列増幅（NASBA）検査、ループ媒介等温増幅アッセイ（LAMP）、単純増幅アッ...

世界の核酸検査市場 2021：企業別、地域別、種類・用途別

Global Nucleic Acid Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z10105 2021年4月 109Pages
当調査資料では、核酸検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。核酸検査の種類別市場規模（転写媒介増幅（TMA）、ポリメラーゼ連鎖反応（PCR）、リガーゼ連鎖反応（LCR）、全ゲノムシーケンス）、用途別市場規模（病院、病理学研究所、研究所、診療...

世界の核酸ゲル染色剤市場 2021：企業別、地域別、種類・用途別

Global Nucleic Acid Gel Stains Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z10103 2021年4月 107Pages
当調査資料では、核酸ゲル染色剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。核酸ゲル染色剤の種類別市場規模（DNA染色、RNA染色）、用途別市場規模（病院研究所、参照研究所、学術研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中...

世界の核酸定量キット市場 2021：企業別、地域別、種類・用途別

Global Nucleic Acid Quantitation Kit Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z10104 2021年4月 108Pages
当調査資料では、核酸定量キットのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。核酸定量キットの種類別市場規模（DNA定量キット、RNA定量キット）、用途別市場規模（病院研究所、参照研究所、学術研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の核酸ベース治療薬市場規模・現状・予測（2021年-2027年） Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of…
世界の核酸増幅検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nucleic Acid Amplification Testing Market The global Nucleic Acid Amplification Testing market size is projected to reach US$ 177.3 million by 2026, from US$ 131.5 million in 2019, at a CAGR of 4.3% during 2021-2026. With industry-standard accuracy in analysis an…
世界の核酸検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Nucleic Acid Testing Market The global Nucleic Acid Testing market size is projected to reach US$ 2730.6 million by 2026, from US$ 1840 million in 2019, at a CAGR of 5.7% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the r…
世界の等温核酸増幅技術（INAAT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indu…
世界の核酸検査市場 2021：企業別、地域別、種類・用途別 The Nucleic Acid Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…